Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

View PDF

AACR 2018. Multifunctional Biologics for Targeted T-cell Therapy Based on Humabody® VH Domains

AACR 2018. Multifunctional Biologics for Targeted T-cell Therapy Based on Humabody® VH Domains Poster

view Poster 

Crescendo Biologics’ Colette Johnston to present at 11th Annual Proteins & Antibodies Congress, London

Crescendo Biologics’ Colette Johnston to present at 11th Annual Proteins & Antibodies Congress, London

view PDF